Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
about
Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta 2 -agonists (LABA) for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS for adults with asthmaRegulator of G Protein Signaling 2: A Versatile Regulator of Vascular FunctionTen years of tiotropium: clinical impact and patient perspectivesLong-acting muscarinic receptor antagonists for the treatment of chronic airway diseasesMapping physiological G protein-coupled receptor signaling pathways reveals a role for receptor phosphorylation in airway contractionThe cellular and molecular basis of bitter tastant-induced bronchodilationTiotropium in asthma: what is the evidence and how does it fit in?Caveolin-1 knockout mice exhibit airway hyperreactivityKaempferol Inhibits Endoplasmic Reticulum Stress-Associated Mucus Hypersecretion in Airway Epithelial Cells And Ovalbumin-Sensitized MiceMuscarinic antagonists in early stage clinical development for the treatment of asthma.Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airwaysThe evidence on tiotropium bromide in asthma: from the rationale to the bedside.Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airwayPro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscleDifferential expression analysis for pathways.Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthmaExpression of functional leukotriene B4 receptors on human airway smooth muscle cells.Muscarinic M3 receptors on structural cells regulate cigarette smoke-induced neutrophilic airway inflammation in miceTiotropium in asthma: a systematic reviewLong-term exposure to muscarinic agonists decreases expression of contractile proteins and responsiveness of rabbit tracheal smooth muscle cellsmAChRs activation induces epithelial-mesenchymal transition on lung epithelial cellsEpithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.Suppression of IL-8 production from airway cells by tiotropium bromide in vitro.Maternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammationTargeted lung denervation for moderate to severe COPD: a pilot study.β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoidsOvercoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trialsCirculating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders.The role of tiotropium in the management of asthma.Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic FibrosisRegional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways.Luminal cholinergic signalling in airway lining fluid: a novel mechanism for activating chloride secretion via Ca²⁺-dependent Cl⁻ and K⁺ channels.Circadian disruption alters mouse lung clock gene expression and lung mechanicsProtective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets
P2860
Q24186370-1E6AE8B6-4154-4196-8D62-C64120C14607Q24187031-3B6CDE31-7105-4FEB-85B2-4DFEE68BAE27Q24187322-D1B8D1DD-13EC-4BF5-9786-D1114551773AQ24187595-91270BDE-7B5C-4822-B2B5-990FD6254562Q24187757-F850A0E9-0FAC-4BF3-97CA-D5B48C781764Q24188213-E6A102DA-8062-487B-B100-EBDDBFC07EFEQ26823214-72FED827-7ED7-41EB-8A16-DEB0E6FD4DA7Q26823682-3D4FBBE1-E97B-4B57-8E4C-2BAEB10D8269Q27022636-58D98C21-95D6-45C1-9897-E0370B7540DBQ27316989-58242814-5CE6-40FB-B14C-B2C6DA8B1E42Q27318226-982010E3-7094-4231-8C8A-4A9F4D2DF4E3Q28067912-B354F1B8-22B4-4319-BAC1-CC4931F7578EQ28389682-4A6ACBC8-C4D9-49E9-A251-AFB28C3BFEA6Q28551099-84AC9352-7545-4822-8575-D523A50493F1Q30396144-0813C548-A73B-48CD-A425-C88D9A060AC6Q33519879-CD5B2EE3-86DE-4EA2-93B6-E2DE70989B95Q33644971-AA918D1F-B2CE-4A12-BA77-3300A7A21D8AQ33896990-85775B4E-0E91-4EDA-AB7B-D755CE628D6CQ34203142-192CB700-C542-47B7-AAF3-056603A49C9EQ34629108-FED601BB-B67C-403E-BB30-680233C509B8Q34698968-4A23B777-CECC-432B-BD68-63F6E0CDAFBCQ34994690-4D9CEFE7-A365-492F-9D6F-8092C2D5446EQ35043468-9AEF2A60-9676-433E-B063-A78772A7EC33Q35112216-E2BCD2EB-88E8-4566-97C4-113487278D88Q35114194-E82CF7DE-99F3-4621-9361-6174CB421314Q35134213-FDA6AA3B-7A38-4F29-95C4-38EA95BB0DA1Q35195548-7BC51282-B073-44DB-A1BC-A63EDEE9E042Q35268308-5FFFD614-2688-46E1-AEAD-7B2E2CB263D5Q35327025-1222A1DB-114C-4491-B8AE-E43DF6B2AB12Q35550788-8CFA5975-A82B-45C3-B86B-2E76A06B27C3Q35621371-4CF558E8-113F-43C7-A8D8-8BFC03B28E03Q35677555-10541CA1-52EE-4E5C-B09A-8C2E2B7C3514Q35829354-A8CB870C-48A0-4660-AED6-219E71A72206Q35937096-56E7CE9E-7855-4BDA-BA7E-63719DEAA81EQ36063173-1AB50DC1-0DAB-44D5-B56F-EA04AF6FE975Q36110580-DCCA07D3-16B5-47E3-B0BC-CBEBFA363687Q36159063-E3A848A1-00D7-4469-9548-AA9EA987BB19Q36184547-D91FC92D-A9D4-48F7-8EA9-BFE02038DCABQ36255835-79773CC5-A3ED-4BFF-A2CE-32523A55B49FQ36316001-D87EB348-1B7B-47D8-AFCA-6E20B146481F
P2860
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@ast
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@en
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@nl
type
label
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@ast
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@en
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@nl
prefLabel
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@ast
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@en
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@nl
P2093
P2860
P921
P356
P1433
P1476
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
@en
P2093
Herman Meurs
Johan Zaagsma
Reinoud Gosens
P2860
P2888
P356
10.1186/1465-9921-7-73
P577
2006-05-09T00:00:00Z
P5875
P6179
1005395823